EGFR and lung carcinoma: Though activating mutations in epidermal growth factor receptor (EGFR) resultes in activate transcription of IL-6 [17], and activated Ras may also lead to IL-6 induction in lung cancer cells [33], the comprehensive mechanisms for IL-6 production in lung cancer cells remain unclear.